Gilead Sciences Shares Trade in the Red for Seventh Consecutive Session (NASDAQ:GILD) by Technical Terrence Team 02/05/2024 0 Sciences of GileadNASDAQ: GOLDEN) shares are trading in the red for the seventh day in a row, falling 0.18% to ...
Eli Lilly Named Gilead Favorite at BofA Ahead of Q3 Earnings by Technical Terrence Team 10/22/2023 0 in focus Heading into the biopharmaceutical sector's third-quarter earnings season, Bank of America has taken a bullish stance on Eli ...
Gilead Trodelvy with Merck’s Keytruda controls lung cancer by Technical Terrence Team 09/10/2023 0 Justin Sullivan/Getty Images News Gilead (NASDAQ:GILD) announced Sunday that its antibody-drug conjugate Trodelvy and Merck’s (NYSE:MRK) anti-PD-1 immunotherapy Keytruda cut ...